Dr Adeniyi Olagunju is a Senior Lecturer in the Department of Pharmacology and Therapeutics and a member of the Centre of Excellence for Long-acting Therapeutics (CELT). He leads the Perinatal Pharmacology Group where research is focused on broadening our understanding of drug safety and efficacy during pregnancy and lactation. Working across three domains (human-relevant in vitro modelling, in silico modelling and clinical research), Dr Olagunju’s vision for his research programme is to transform the assessment of drug safety during pregnancy by developing a platform that will generate human pregnancy-relevant safety information early in drug development. This will facilitate decisions about safe inclusion of pregnant women in early-phase clinical trials, enabling evidence-based, pregnancy-specific recommendations for potentially life-saving therapeutics. He is primarily funded by the Wellcome Trust.
